Professor | Shuai Xia | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Shuai Xia
Contact Information	sxia15@fudan.edu.cn
Language ability	Chinese, English
Province	Shanghai

Upload Avatar (500 x 500)

Name

Shuai Xia

Contact Information

sxia15@fudan.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2008.09—2013.09 Bachelor's in Medical Laboratory Science: Bengbu Medical College 2013.09—2018.07 PhD in Pathogen Biology: Fudan University
Work Experience	2018.07—2021.1 - Fudan University - Postdoctoral Researcher 2021.02—Present - Fudan University - Junior Researcher
Awards	2019: Fudan University Outstanding Postdoctoral Award 2020: 'One Health Fund' COVID-19 Pandemic Control Special Award, Third Prize for Excellent Teacher 2021: Sixth China Association for Science and Technology Outstanding Scientific Paper Award

University/Lab Affiliation and Title

Fudan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2008.09—2013.09 Bachelor's in Medical Laboratory Science: Bengbu Medical College
2013.09—2018.07 PhD in Pathogen Biology: Fudan University

Work Experience

2018.07—2021.1 - Fudan University - Postdoctoral Researcher
2021.02—Present - Fudan University - Junior Researcher

Awards

2019: Fudan University Outstanding Postdoctoral Award
2020: 'One Health Fund' COVID-19 Pandemic Control Special Award, Third Prize for Excellent Teacher
2021: Sixth China Association for Science and Technology Outstanding Scientific Paper Award

Areas of Focus	Mechanism of Human Coronavirus Infection Broad-Spectrum Inhibitors of Human Coronavirus Entry
Publications	Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant, Xia, Shuai; Chan, Jasper Fuk-Woo; Wang, Lijue; Jiao, Fanke; Kenn Ka-Heng Chik; Chu, Hin; Lan, Qiaoshuai; Xu, Wei; Wang, Qian; Wang, Chao; Yuen, Kwok-Yung; Lu, Lu; Jiang, Shibo, 2022 Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Xia, Shuai; Liu, Meiqin; Wang, Chao; Xu, Wei; Lan, Qiaoshuai; Feng, Siliang; Qi, Feifei; Bao, Linlin; Du, Lanying; Liu, Shuwen; Qin, Chuan; Sun, Fei; Shi, Zhengli; Zhu, Yun; Jiang, Shibo; Lu, Lu, 2020 Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation, Xia, Shuai; Lan, Qiaoshuai; Zhu, Yun; Wang, Chao; Xu, Wei; Li, Yutang; Wang, Lijue; Jiao, Fanke; Zhou, Jie; Hua, Chen; Wang, Qian; Cai, Xia; Wu, Yang; Gao, Jie; Liu, Huan; Sun, Ge; Jan Münch; Frank Kirchhoff; Yuan, Zhenghong; Xie, Youhua; Sun, Fei; Jiang, Shibo; Lu, Lu, 2021 The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin, Xia, Shuai; Lan, Qiaoshuai; Su, Shan; Wang, Xinling; Xu, Wei; Liu, Zezhong; Zhu, Yun; Wang, Qian; Lu, Lu; Jiang, Shibo, 2020 A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike, Xia, Shuai; Yan, Lei; Xu, Wei; Agrawal, Anurodh Shankar; Algaissi, Abdullah; Tseng, Chien Te K; Wang, Qian; Du, Lanying; Tan, Wenjie; Wilson, IanA; Jiang, Shibo; Yang, Bei; Lu, Lu, 2019

Areas of Focus

Mechanism of Human Coronavirus Infection
Broad-Spectrum Inhibitors of Human Coronavirus Entry

Publications

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant, Xia, Shuai; Chan, Jasper Fuk-Woo; Wang, Lijue; Jiao, Fanke; Kenn Ka-Heng Chik; Chu, Hin; Lan, Qiaoshuai; Xu, Wei; Wang, Qian; Wang, Chao; Yuen, Kwok-Yung; Lu, Lu; Jiang, Shibo, 2022
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Xia, Shuai; Liu, Meiqin; Wang, Chao; Xu, Wei; Lan, Qiaoshuai; Feng, Siliang; Qi, Feifei; Bao, Linlin; Du, Lanying; Liu, Shuwen; Qin, Chuan; Sun, Fei; Shi, Zhengli; Zhu, Yun; Jiang, Shibo; Lu, Lu, 2020
Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation, Xia, Shuai; Lan, Qiaoshuai; Zhu, Yun; Wang, Chao; Xu, Wei; Li, Yutang; Wang, Lijue; Jiao, Fanke; Zhou, Jie; Hua, Chen; Wang, Qian; Cai, Xia; Wu, Yang; Gao, Jie; Liu, Huan; Sun, Ge; Jan Münch; Frank Kirchhoff; Yuan, Zhenghong; Xie, Youhua; Sun, Fei; Jiang, Shibo; Lu, Lu, 2021
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin, Xia, Shuai; Lan, Qiaoshuai; Su, Shan; Wang, Xinling; Xu, Wei; Liu, Zezhong; Zhu, Yun; Wang, Qian; Lu, Lu; Jiang, Shibo, 2020
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike, Xia, Shuai; Yan, Lei; Xu, Wei; Agrawal, Anurodh Shankar; Algaissi, Abdullah; Tseng, Chien Te K; Wang, Qian; Du, Lanying; Tan, Wenjie; Wilson, IanA; Jiang, Shibo; Yang, Bei; Lu, Lu, 2019

Coronavirus Infection Mechanism Inhibitors Broad-Spectrum Human Entry Research Pathogen Biology

Kong Wei - Peking University

Lizhi Leng - Central South University

Sun Lang - Central South University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us